105 search results
- Current search:
- Drugs and Alcohol
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
TitlePublished 18 Jul 2017
Dexmetomedine for alcohol withdrawal syndrome
Drugs and Alcohol Group Miguel Tolosa-Rodriguez Title Sunday, July 16, 2017 ... -
Cochrane EvidencePublished 29 May 2017
Use of opioid antagonists with minimal sedation to manage opioid withdrawal
Review question We reviewed the evidence on the effects of opioid antagonists (naltrexone, naloxone) plus minimal sedation for managing withdrawal in people who are dependent on opioid drugs (for example, heroin or pharmaceutical opiates). Background Managed withdrawal, or detoxification, is a required first step for longer-term treatments of opioid ... -
Cochrane EvidencePublished 27 Apr 2017
Supervised-dosing strategies versus take-home opioid substitution treatment for people dependent on opioid drugs
Review question We reviewed the evidence about the effectiveness of supervised dosing strategies in opioid substitution treatment for people dependent on opioid drugs. Background Opioid dependence (OD) is a global clinical and public health problem that is associated with significant burden of disease and drug-related deaths. OD represents a complex ... -
Cochrane EvidencePublished 3 Mar 2017
Music therapy for people with substance use disorders
Protocol: Main objective To assess the effects of music therapy, as a primary or a supportive intervention, compared to standard care, wait-list control or no treatment, for people with substance use disorders, to reduce substance use,the severity of substance dependence/abuse, psychological symptoms, and substance craving; to enhance motivation ... -
TitlePublished 23 Apr 2017
Alcoholics Anonymous and other 12-step programmes for alcohol use disorder
Drugs and Alcohol Group John Kelly Title Thursday, February 23, 2017 ... -
Cochrane EvidencePublished 21 Feb 2017
Buprenorphine for managing opioid withdrawal
Review question We reviewed the evidence about the effect of buprenorphine for managing withdrawal in people who are dependent on opioid drugs (for example, heroin or pharmaceutical opiates). Background Managed withdrawal, or detoxification, is a required first step for long-term treatment of opioid dependence. The combination of uncomfortable symptoms ... -
Cochrane EvidencePublished 16 Feb 2017
Baclofen for alcohol use disorder
Protocol: To assess the efficacy and safety of baclofen for managing patients with alcohol use disorder. -
Cochrane EvidencePublished 29 Sep 2016
Psychosocial interventions for cocaine and amphetamines abusers
Review question We reviewed the evidence about the effect of psychosocial treatment, which encompasses a wide variety of strategies that aim to change behaviour and support adults who are affected by harmful use, abuse or dependence on cocaine or amphetamines, including MDMA (ecstasy). Background Globally, cocaine and amphetamines are the two main ... -
Cochrane EvidencePublished 27 Sep 2016
Efficacy of psychostimulant drugs for cocaine dependence
Review question We investigated whether psychostimulant substitution was safe and effective for treating patients with cocaine dependence. Background Cocaine dependence is a frequent disorder for which no medication has been approved for treatment. Substitution therapy involves the replacement of the abused drug, which is often illegal and used ... -
Cochrane EvidencePublished 2 Aug 2016
Family-based prevention programs for alcohol use in young people
Protocol: To assess the effectiveness of universal, selective and indicated family-based prevention programs in preventing alcohol use, or problem drinking, in school-aged children (up to 18 years of age). Specifically, on these outcomes, the review aims: To assess the effectiveness of universal family-based prevention programs for all children ...
